30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

ESSA Pharma Inc (EPIX)

Track

Stock chart
Ticker: EPIX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
BVF PARTNERS L P/IL
3 sales — total 293 USD
Sale 5 Aug 2025
Value US$3,450,878.55 | Price 176.93 | Shares 1,608
Sale 5 Aug 2025
Value US$314,650.75 | Price 40.65 | Shares 45,734
Sale 5 Aug 2025
Value US$148.35 | Price 1.88 | Shares 79
Sale 1 Nov 2024
Value US$2,238,911.89 | Price 278.51 | Shares 24,787
Sale 1 Nov 2024
Value US$1,757,378.26 | Price 168.62 | Shares 77,133
Sale 1 Nov 2024
Value US$3,051,800.00 | Price 1.53 | Shares 2,000,000
Sale 1 Nov 2024
Value US$3,064,000.00 | Price 1.53 | Shares 2,000,000
Planned sale 7 Oct 2024
Value US$4,184.82 | Price 6.03 | Shares 694
Planned sale 7 Oct 2024
Value US$4,184.82 | Price 6.03 | Shares 694
Planned sale 9 Sep 2024
Value US$4,164.00 | Price 6.00 | Shares 694
Planned sale 9 Sep 2024
Value US$4,164.00 | Price 6.00 | Shares 694
Proposed sale 3 Sep 2024
Value US$23,276.76 | Price 5.59 | Shares 4,164
Planned sale 3 Sep 2024
Value US$12,554.46 | Price 6.03 | Shares 2,082
Planned sale 3 Sep 2024
Value US$12,554.46 | Price 6.03 | Shares 2,082
Planned sale 6 May 2024
Value US$4,823.30 | Price 6.95 | Shares 694
Proposed sale 5 Apr 2024
Value US$16,989.12 | Price 8.16 | Shares 2,082
Planned sale 5 Apr 2024
Value US$5,510.36 | Price 7.94 | Shares 694
Planned sale 5 Apr 2024
Value US$5,509.67 | Price 7.94 | Shares 694
Planned sale 5 Mar 2024
Value US$6,232.12 | Price 8.98 | Shares 694
Planned sale 6 Feb 2024
Value US$748,926.78 | Price 10.29 | Shares 72,782
Planned sale 5 Feb 2024
Value US$5,020.00 | Price 10.04 | Shares 500
Planned sale 5 Feb 2024
Value US$6,419.50 | Price 9.25 | Shares 694
Planned sale 16 Jan 2024
Value US$17,197.18 | Price 10.01 | Shares 1,718
Proposed sale 16 Jan 2024
Value US$745,500.00 | Price 9.94 | Shares 75,000
Planned sale 5 Jan 2024
Value US$4,270.89 | Price 6.11 | Shares 699
Planned sale 5 Jan 2024
Value US$4,270.89 | Price 6.11 | Shares 699
Proposed sale 5 Jan 2024
Value US$12,876.79 | Price 6.17 | Shares 2,087
Buy 14 Dec 2023
Value US$21,249.79 | Price 2.30 | Shares 9,223
Planned buy 14 Dec 2023
Value US$21,212.90 | Price 2.30 | Shares 9,223
Buy 21 Nov 2023
Value US$134,821.17 | Price 5.73 | Shares 23,529
Buy 21 Nov 2023
Value US$133,274.07 | Price 5.73 | Shares 23,259
Buy 3 Nov 2023
Value US$98,661.29 | Price 5.99 | Shares 16,471
Buy 2 Nov 2023
Value US$321,000.00 | Price 5.35 | Shares 60,000
Planned buy 30 Dec 2022
Value US$21,585.20 | Price 2.60 | Shares 8,302
Planned buy 30 Dec 2022
Value US$7,974.20 | Price 2.60 | Shares 3,067
Planned buy 30 Dec 2022
Value US$7,974.20 | Price 2.60 | Shares 3,067
Planned buy 30 Dec 2022
Value US$21,585.20 | Price 2.60 | Shares 8,302
Buy 22 Dec 2022
Value US$51,067.13 | Price 2.39 | Shares 21,367
Buy 22 Dec 2022
Value US$51,067.13 | Price 2.39 | Shares 21,367
Sale 21 Dec 2022
Value US$83,088.28 | Price 2.42 | Shares 34,334
Sale 21 Dec 2022
Value US$91,312.49 | Price 2.41 | Shares 37,889
Sale 21 Dec 2022
Value US$83,088.28 | Price 2.42 | Shares 34,334
Sale 21 Dec 2022
Value US$91,312.49 | Price 2.41 | Shares 37,889
Sale 20 Dec 2022
Value US$110,351.01 | Price 2.53 | Shares 43,617
Sale 20 Dec 2022
Value US$110,351.01 | Price 2.53 | Shares 43,617
Sale 16 Dec 2022
Value US$133,500.00 | Price 2.67 | Shares 50,000
Sale 16 Dec 2022
Value US$133,500.00 | Price 2.67 | Shares 50,000
Sale 15 Dec 2022
Value US$143,000.00 | Price 2.86 | Shares 50,000
Sale 15 Dec 2022
Value US$92,800.00 | Price 2.90 | Shares 32,000
Sale 15 Dec 2022
Value US$143,000.00 | Price 2.86 | Shares 50,000
Sale 15 Dec 2022
Value US$92,800.00 | Price 2.90 | Shares 32,000
Sale 14 Dec 2022
Value US$75,000.00 | Price 3.00 | Shares 25,000
Sale 14 Dec 2022
Value US$75,000.00 | Price 3.00 | Shares 25,000
Buy 27 Oct 2022
Value US$2,251,100.00 | Price 4.50 | Shares 500,000
Buy 26 Oct 2022
Value US$5,968,500.00 | Price 3.98 | Shares 1,500,000
Buy 18 Jul 2022
Value US$946,740.00 | Price 3.16 | Shares 300,000
Buy 15 Jul 2022
Value US$756,798.11 | Price 3.13 | Shares 241,665
Buy 14 Jul 2022
Value US$969,428.29 | Price 2.79 | Shares 347,204
Buy 30 Jun 2022
Value US$14,455.75 | Price 2.96 | Shares 4,887
Sale 27 Apr 2022
Value US$146,925.36 | Price 5.85 | Shares 25,100
Buy 22 Feb 2021
Value US$1,539,000.00 | Price 27.00 | Shares 57,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-07 2025-08-05 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,608 +13.7%
176.93
US$3,450,879 		1,608 +13.7% 176.93 US$3,450,879
2025-08-07 2025-08-05 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
45,734 -35.8%
40.65
US$314,651 		45,734 -35.8% 40.65 US$314,651
2025-08-07 2025-08-05 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
14,069 +21.5%
299.21
US$1,550,061 		14,069 +21.5% 299.21 US$1,550,061
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
1,879,583 -100.0%
1.51
US$2,843,809 		1,879,583 -100.0% 1.51 US$2,843,809
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
2,000,000 -51.6%
1.53
US$3,058,800 		2,000,000 -51.6% 1.53 US$3,058,800
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
2,000,000 -34.0%
1.53
US$3,051,800 		2,000,000 -34.0% 1.53 US$3,051,800
2024-11-05 2024-11-01 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
2,000,000 -25.4%
1.53
US$3,064,000 		2,000,000 -25.4% 1.53 US$3,064,000
2024-10-07 2024-10-07 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
694 -8.2%
6.03
US$4,185 		694 -8.2% 6.03 US$4,185
2024-10-07 2024-10-07 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -8.2%
6.03
US$4,185 		694 -8.2% 6.03 US$4,185
2024-09-09 2024-09-09 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
694 -7.6%
6.00
US$4,164 		694 -7.6% 6.00 US$4,164
2024-09-09 2024-09-09 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -7.6%
6.00
US$4,164 		694 -7.6% 6.00 US$4,164
2024-09-03 2024-09-03 PrS Proposed sale
Virsik Peter

Officer

Officer
4,164
5.59
US$23,277 		4,164 5.59 US$23,277
2024-09-03 2024-09-03 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
2,082 -18.5%
6.03
US$12,554 		2,082 -18.5% 6.03 US$12,554
2024-09-03 2024-09-03 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
2,082 -18.5%
6.03
US$12,554 		2,082 -18.5% 6.03 US$12,554
2024-05-06 2024-05-06 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -5.8%
6.95
US$4,823 		694 -5.8% 6.95 US$4,823
2024-04-05 2024-04-05 PrS Proposed sale
Virsik Peter

Officer

Officer
2,082
8.16
US$16,989 		2,082 8.16 US$16,989
2024-04-05 2024-04-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -5.5%
7.94
US$5,510 		694 -5.5% 7.94 US$5,510
2024-04-05 2024-04-05 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
694 -5.5%
7.94
US$5,510 		694 -5.5% 7.94 US$5,510
2024-03-05 2024-03-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -5.2%
8.98
US$6,232 		694 -5.2% 8.98 US$6,232
2024-02-07 2024-02-06 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
72,782 -84.5%
10.29
US$748,927 		72,782 -84.5% 10.29 US$748,927
2024-02-06 2024-02-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
500 -3.6%
10.04
US$5,020 		500 -3.6% 10.04 US$5,020
2024-02-06 2024-02-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
694 -4.9%
9.25
US$6,420 		694 -4.9% 9.25 US$6,420
2024-01-17 2024-01-16 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
1,718 -10.9%
10.01
US$17,197 		1,718 -10.9% 10.01 US$17,197
2024-01-16 2024-01-16 PrS Proposed sale
Virsik Peter

Officer

Officer
75,000
9.94
US$745,500 		75,000 9.94 US$745,500
2024-01-11 2024-01-05 PlS Planned sale
Virsik, Peter

Director of Issuer

Non-Executive Director
699 -4.7%
6.11
US$4,271 		699 -4.7% 6.11 US$4,271
2024-01-08 2024-01-05 PlS Planned sale
Virsik Peter

Chief Operating Officer

Officer
699 -4.7%
6.11
US$4,271 		699 -4.7% 6.11 US$4,271
2024-01-05 2024-01-05 PrS Proposed sale
Virsik Peter

Officer

Officer
2,087
6.17
US$12,877 		2,087 6.17 US$12,877
2023-12-18 2023-12-14 B Purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
9,223 +16.3%
2.30
US$21,250 		9,223 +16.3% 2.30 US$21,250
2023-12-18 2023-12-14 PP Planned purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
9,223 +16.3%
2.30
US$21,213 		9,223 +16.3% 2.30 US$21,213
2023-11-22 2023-11-21 B Purchase
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
23,529 +3.1%
5.73
US$134,821 		23,529 +3.1% 5.73 US$134,821
2023-11-22 2023-11-21 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
23,259 +3.1%
5.73
US$133,274 		23,259 +3.1% 5.73 US$133,274
2023-11-16 2023-11-03 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
16,471 +2.2%
5.99
US$98,661 		16,471 +2.2% 5.99 US$98,661
2023-11-16 2023-11-02 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
60,000 +8.8%
5.35
US$321,000 		60,000 +8.8% 5.35 US$321,000
2023-01-05 2022-12-30 PP Planned purchase
Wood, David Sidney

Senior Officer of Issuer

Officer
8,302 +33.2%
2.60
US$21,585 		8,302 +33.2% 2.60 US$21,585
2023-01-05 2022-12-30 PP Planned purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
3,067 +5.7%
2.60
US$7,974 		3,067 +5.7% 2.60 US$7,974
2023-01-05 2022-12-30 PP Planned purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
3,067 +5.7%
2.60
US$7,974 		3,067 +5.7% 2.60 US$7,974
2023-01-05 2022-12-30 PP Planned purchase
Wood David S.

Chief Financial Officer

Officer
8,302 +33.2%
2.60
US$21,585 		8,302 +33.2% 2.60 US$21,585
2023-01-05 2022-12-22 B Purchase
3.2
Parkinson, David

Director of Issuer

Non-Executive Director
21,367 +66.5%
2.39
US$51,067 		21,367 +66.5% 2.39 US$51,067
2023-01-05 2022-12-22 B Purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
21,367 +66.5%
2.39
US$51,067 		21,367 +66.5% 2.39 US$51,067
2023-01-05 2022-12-21 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
34,334 -4.8%
2.42
US$83,088 		34,334 -4.8% 2.42 US$83,088
2023-01-05 2022-12-21 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
37,889 -5.0%
2.41
US$91,312 		37,889 -5.0% 2.41 US$91,312
2023-01-05 2022-12-21 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
34,334 -4.8%
2.42
US$83,088 		34,334 -4.8% 2.42 US$83,088
2023-01-05 2022-12-21 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
37,889 -5.0%
2.41
US$91,312 		37,889 -5.0% 2.41 US$91,312
2023-01-05 2022-12-20 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
43,617 -5.5%
2.53
US$110,351 		43,617 -5.5% 2.53 US$110,351
2023-01-05 2022-12-20 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
43,617 -5.5%
2.53
US$110,351 		43,617 -5.5% 2.53 US$110,351
2023-01-05 2022-12-16 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.9%
2.67
US$133,500 		50,000 -5.9% 2.67 US$133,500
2023-01-05 2022-12-16 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
50,000 -5.9%
2.67
US$133,500 		50,000 -5.9% 2.67 US$133,500
2023-01-05 2022-12-15 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.6%
2.86
US$143,000 		50,000 -5.6% 2.86 US$143,000
2023-01-05 2022-12-15 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
32,000 -3.4%
2.90
US$92,800 		32,000 -3.4% 2.90 US$92,800
2023-01-05 2022-12-15 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
50,000 -5.6%
2.86
US$143,000 		50,000 -5.6% 2.86 US$143,000
2023-01-05 2022-12-15 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
32,000 -3.4%
2.90
US$92,800 		32,000 -3.4% 2.90 US$92,800
2023-01-05 2022-12-14 S Sale
3.4
BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
25,000 -2.6%
3.00
US$75,000 		25,000 -2.6% 3.00 US$75,000
2023-01-05 2022-12-14 S Sale
2.3
BERGER FRANKLIN M
Non-Executive Director
25,000 -2.6%
3.00
US$75,000 		25,000 -2.6% 3.00 US$75,000
2022-10-28 2022-10-27 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
500,000 +6.8%
4.50
US$2,251,100 		500,000 +6.8% 4.50 US$2,251,100
2022-10-28 2022-10-26 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
1,500,000 +25.5%
3.98
US$5,968,500 		1,500,000 +25.5% 3.98 US$5,968,500
2022-07-20 2022-07-18 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
300,000 +5.4%
3.16
US$946,740 		300,000 +5.4% 3.16 US$946,740
2022-07-18 2022-07-15 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
241,665 +4.5%
3.13
US$756,798 		241,665 +4.5% 3.13 US$756,798
2022-07-18 2022-07-14 B Purchase
2.1
BIOTECH GROWTH N V
Large shareholder
347,204 +7.0%
2.79
US$969,428 		347,204 +7.0% 2.79 US$969,428
2022-07-05 2022-06-30 B Purchase
3.2
Parkinson David Ross

Chief Executive Officer

Executive Director
4,887 +18.0%
2.96
US$14,456 		4,887 +18.0% 2.96 US$14,456
2022-04-28 2022-04-27 S Sale
2.1
BIOTECH GROWTH N V
Large shareholder
25,100 -0.5%
5.85
US$146,925 		25,100 -0.5% 5.85 US$146,925
2021-03-04 2021-02-22 B Purchase
2.3
BERGER FRANKLIN M
Non-Executive Director
57,000 +6.3%
27.00
US$1,539,000 		57,000 +6.3% 27.00 US$1,539,000
Explore more

More insider trading research around ESSA Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America